[Immunotherapy study in the treatment of metastatic renal cancer in the adult].
Metastatic renal cancer is one of the models used for immunotherapy study. Interleukin-2 is active in this chemo and radioresistant tumour and induces the regression of diffuse metastatic lesions sometimes completely through the activation of the immune system. Interleukin-2 has also led to the development of new therapeutic approaches in oncology such as TIL and gene transfer.
Philip
T
T
Centre Léon Bérard, Lyon.
Negrier
S
S
D000328:Adult; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis
Expérience de l'immunothérapie dans le traitement du cancer du rein métastatique de l'adulte.